NEW YORK, Aug. 26, 2025 /PRNewswire/ — RethinkFirst, a leading global health technology company and solutions provider in behavioral health and neurodiversity, today announced that it has been recognized for its exceptional growth and innovation, securing a place on the Inc. 5000 list of the nation’s fastest-growing private companies for the seventh consecutive year.
“Earning a place on the Inc. 5000 year after year is an achievement for only a small percentage of companies. This acknowledgment is more than a growth milestone for RethinkFirst—it’s a testament to the important work we do to improve lives,” said Ben Semmes, CEO of RethinkFirst. “We’re driven by a single purpose: expanding access to effective behavioral health care. With millions now benefiting from our solutions, we remain focused on delivering innovations that support healthier, more fulfilling lives worldwide.”
RethinkFirst provides cloud-based behavioral health solutions designed to empower individuals and organizations. With its scalable, evidence-based tools, training and clinical expertise, RethinkFirst leverages data science, analytics and artificial intelligence (AI) to improve outcomes and enable value-based care across diverse communities. The solutions are designed to support a range of individuals—including K-12 students and educators, working parents, caregivers, clinicians, payors, neurodivergent individuals and their families.
About Rethink
Rethink is a global health technology company providing cloud-based treatment tools, training and clinical support to employers, educators, payors and behavioral health professionals. Rethink’s award-winning solutions serve 11+ million employees worldwide, one-third of Fortune 100 companies, many of the country’s largest public-school districts, and over 96,000 individual behavioral healthcare providers. Each of Rethink’s award-winning solutions incorporates evidence-based protocols, workflow automation, and advanced data analytics to drive meaningful clinical outcomes and improved performance for customers and the communities that they serve. For more information, please visit our Rethink website or for media inquiries email press@rethinkfirst.com.
SOURCE RethinkFirst
TAMPA, FL / ACCESS Newswire / December 26, 2025 / Key TakeawaysWhat it claims: Nerve…
Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…
NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…